21
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Analide derivatives as monocyte chemoattractant protein-1 receptor antagonists

Pages 711-715 | Published online: 25 Feb 2005

Bibliography

  • ROLLINS B, WALZ A, BAGGOLINI M: Recombinant human monocyte chemotactic protein-1/JE induces calcium flux and the respiratory burst in human monocytes. Blood (1991) 78:1112–1116.
  • CARR MW, ROTH SJ, LUTHER E, ROSE SS, SPRINGER TA: Monocyte chemoattractant protein-1 acts as a T lymphocyte chemoattractant. Proc. Natl. Acad. Sci. (1994) 91:3652–3656.
  • KUNA P, REDDAGARI TJ, SEHALL D et al.: Characterisa-tion of the human basophil response to cytokines, growth factors and histamine releasing factors of the intercrine/chemokine family. J. Immunol. (1993) 150:1932–1943.
  • STREITER RM, WIGGINS SH, PHAN BL et al.: Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun. (1989) 162:694–700.
  • YOSHIMURA T, YUKHI N, MOORE SK et al.: Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear cells and sequence similarity to mouse competence gene JE. FEBS Lett. (1989) 244:487–493.
  • CUSHING SD, BERLINER JA, VALENTE AJ et al.: Minimally modified low density lipoprotein induces monocyte chemoatactic protein-1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. (1990) 87:5134–5138.
  • WONG LM, MYERS SJ, TSOU CL, GOSLING J, ARAI H,CHARO IF: Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J. Biol. Chem. (1997) 272:1038–1045.
  • FRANCI C, WONG LM, VAN DAMME J, PROOST P, CHAROIF: Monocyte chemoattractant protein-3 but not monocyte chemoattractant protein-2 is a functional ligand of the MCP-1 receptor. J. Immunol. (1995) 154:6511–6517.
  • GARCIA-ZEPEDA EA, COMBADIERE C, ROTHENBURG MN et al.: Human monocyte chemoattractant protein-4 (MCP-4) is a novel CC chemokine with activities on moncytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors CCR-2 and -3. J. Immunol. (1996) 157:5613–5626.
  • SARAFI MN, GARCIA-ZEPEDA EA, MACLEAN JA, CHARO IF, LUSTER AD: Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. (1997) 185:99–109.
  • DORANZ BJ, RUCKER J, YI Y et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors, CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell (1996) 85:1149–1158.
  • SMITH MW, DEAN M, CARRINGTON M: Contrasting genetic influence of CCR2 and CCR5variants on HIV-1 infection and disease progression. Science (1997) 15:959–965.
  • NELKEN NA, COUGHLIN SR, GORDON D, WILCOX JN:Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin. Invest (1991) 88:1121–1127.
  • YU X, DLUZ S, GRAVES DT et al.: Elevated expression ofMCP-1 by vascular smooth muscle cells in hypercho-lesterolemic primates. Proc. Natl. Acad. Sci. USA (1992) 89:6953–6957.
  • RANSOHOFF RM, HAMILTON TA, TANI M et al.: Astrocyteexpression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmunne enchephalo-myelitis. FASEB J(1993) 7:592–600.
  • KOCH AE, KUNKEL SL, HARLOW LA et al.: Enhancedproduction of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. (1992) 90:772–779.
  • YAMASHIRO S, TAKEYA M, KURATSU J et al.: Intradermalinjection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin. Int. Arch. Allergy Immunol (1998) 115:15–23.
  • JONES ML, MULLIGAN MS, FLORY CM, WARD PA, WARREN JS: Potential role of monocyte chemoattrac-tant protein 1 /JE in monocyte/macrophage dependant IgA immune complex alveolitis in the rat. J. Immunol. (1992) 149:2147–2154.
  • FUENTES ME, DURHAM SK, SWERDEL MR et al.: Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein -1.1 Immunol. (1995) 155:5796–5776.
  • LU B, RUTLEDGE BJ, LONG G et al.: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1 deficient mice. J. Exp. Med. (1998) 187:601–608.
  • BORING L, GOSLING J, CHENSUE SW et al.: Impaired monocyte migration and reduced Type 1 (Thl) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. (1997) 100:2552–2561.
  • GOSLING J, SLAYMAKER S, GU L et al.: MCP-1 deficiencyreduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin Invest. (1999) 103:773–8.
  • BORING L, GOSLING H, CLEARY M. CHARO IF: Decreasedlesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (1998) 394:894–897.
  • GONG JH, CLARK-LEWIS I: Antagonists of monocytechemoattractant protein-1 identified by modification of functionally critical NH2-terminal residues. J. Exp. Med. (1995) 181:631–640.
  • SCHALL TJ, BACON K, TOY KJ, GOEDDEL DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (1990) 347:669–671.
  • MAGAZIN M, GUILLEMOT JC, VITA N, FERRARA P: Interleukin-13 is a monocyte chemoattractant. European Cytokine Network (1994) 5:397–400.
  • BAR-SHAVIT R, KAHN A, FENTON JW, WILNER GD: Chemotactic response of monocytes to thrombin. J. Cell Biol. (1983) 96:282–285.
  • SYRO VETS T, TIPPLER B, RIEKS M, SIMMET T: Plamin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependant pathway. Blood (1997) 89:4574–4583.
  • GU L, TSENG SC, ROLLINS BJ: Monocyte chemoattrac- tant, protein- 1. Chem. Immunol. (1999) 72:7–29.
  • ••Good and comprehensive review.
  • CHARO IF: CCR2: from cloning to the creation of knockout, mice. Chem. Immunol. (1999) 72:30–41.
  • ••Good and comprehensive review.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.